$263 Million is the total value of HAMILTON LANE ADVISORS LLC's 52 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CPTA | New | Capitala Financial Corp | $8,305,000 | – | 464,799 | +100.0% | 3.15% | – |
| GDOT | New | Green Dot Corp. | $5,597,000 | – | 273,157 | +100.0% | 2.12% | – |
| VEEV | New | Veeva Systems, Inc. | $5,084,000 | – | 192,521 | +100.0% | 1.93% | – |
| GRUB | New | GrubHub, Inc. | $3,731,000 | – | 102,730 | +100.0% | 1.42% | – |
| LDRH | New | LDR Holding Corporation | $3,108,000 | – | 94,813 | +100.0% | 1.18% | – |
| New | Barracuda Networks, Inc. | $2,833,000 | – | 79,032 | +100.0% | 1.08% | – | |
| QIHU | New | Qihoo 360 Technology Co | $2,623,000 | – | 45,807 | +100.0% | 1.00% | – |
| NOAH | New | Noah Holdings Ltd. | $2,106,000 | – | 100,776 | +100.0% | 0.80% | – |
| WPZ | New | Williams Partners LP | $2,078,000 | – | 46,431 | +100.0% | 0.79% | – |
| AGTC | New | Applied Genetic Technologies | $1,765,000 | – | 83,951 | +100.0% | 0.67% | – |
| XLRN | New | Acceleron Pharma, Inc. | $1,658,000 | – | 42,549 | +100.0% | 0.63% | – |
| GPRO | New | GoPro, Inc. | $1,620,000 | – | 25,626 | +100.0% | 0.62% | – |
| IMDZ | New | Immune Design Corp | $1,318,000 | – | 42,812 | +100.0% | 0.50% | – |
| JD | New | JD.com, Inc. | $611,000 | – | 26,393 | +100.0% | 0.23% | – |
| New | Ardelyx, Inc. | $594,000 | – | 31,463 | +100.0% | 0.23% | – | |
| NKTR | New | Nektar Therapeutics | $565,000 | – | 36,471 | +100.0% | 0.22% | – |
| MKTO | New | Marketo, Inc. | $551,000 | – | 16,853 | +100.0% | 0.21% | – |
| ZEN | New | Zendesk, Inc. | $534,000 | – | 21,893 | +100.0% | 0.20% | – |
| CVT | New | Cvent, Inc. | $336,000 | – | 12,084 | +100.0% | 0.13% | – |
| MGNX | New | MacroGenics, Inc. | $323,000 | – | 9,201 | +100.0% | 0.12% | – |
| MVNR | New | Mavenir Systems Inc. | $299,000 | – | 22,050 | +100.0% | 0.11% | – |
| New | Alimera Sciences, Inc. | $240,000 | – | 43,283 | +100.0% | 0.09% | – | |
| SYN | New | Synthetic Biologics, Inc. | $35,000 | – | 23,855 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-01-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Square, Inc. | 24 | Q2 2023 | 20.3% |
| Okta, Inc. | 23 | Q2 2023 | 9.5% |
| Natera, Inc. | 21 | Q2 2023 | 1.6% |
| Twilio, Inc. | 20 | Q2 2022 | 13.1% |
| Synthetic Biologics, Inc. (R14 | 20 | Q2 2018 | 0.0% |
| DocuSign, Inc. | 19 | Q2 2023 | 23.4% |
| Facebook, Inc. | 18 | Q1 2018 | 26.8% |
| Yelp Inc. | 18 | Q3 2017 | 7.8% |
| Elastic N.V. | 18 | Q2 2023 | 6.4% |
| Zendesk, Inc. | 18 | Q1 2019 | 2.7% |
View HAMILTON LANE ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Boxed, Inc. | February 27, 2023 | 3,390,573 | 4.6% |
| WhiteHorse Finance, Inc. | February 13, 2020 | 496,591 | 2.4% |
View HAMILTON LANE ADVISORS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-06-03 |
| 13F-HR/A | 2024-06-03 |
| 13F-HR/A | 2024-06-03 |
| 13F-HR/A | 2024-06-03 |
| 13F-HR/A | 2024-05-28 |
| 13F-HR | 2024-05-01 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-07 |
View HAMILTON LANE ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.